BINKO Memo 80 mg film -coated tablets, 60 pcs

Instructions for use for BINKO Memo 80 mg film -coated tablets, 60 pcs

Detailed instructions for BINKO Memo 80 mg film -coated tablets, 60 pcs

Field of use

Binko Memo 80 mg film-coated tablets (package size: 60 pc) is a recognized, vegetable medicine that contains an extract from Ginkgo Biloba leaves as an active ingredient. Binko® Memo supports the treatment of age -related forgetfulness and lack of concentration as well as the quality of life with slight dementia by improving blood flow to the fine vessels of the inner ear and the brain.

Active ingredients / ingredients / ingredients

80 mg ginkgo leaves dry extract, (35-67: 1), extractor: acetone 60% (m/m)
Ginkgo flavonoid glycosides
Ginkgolide A+B+C
Bilobalide
Ginkgolic acids
Cellulose, microcrystalline auxiliary material (+)
Crooscarmellosis, sodium salt auxiliary material (+)
Iron (III) hydroxide oxide x-water Hedge substance (+)
Glucose syrup, spray -dried auxiliary substance (+)
Lactose 1-water auxiliary substance (+)
Macrogol 3350 Hedge material (+)
Magnesium stair (Ph. EUR.) [pflanzlich] Hedge substance (+)
Poly (vinyl alcohol) auxiliary material (+)
Silicium dioxide, high disperser auxiliary substance (+)
Talcum auxiliary material (+)
Titan dioxide HILDBOFT (+)
23 mg total sodium ion hedge material (+)
Total sodium ion helper (+)

Contradictions

• The medicine must not be taken
  • if you are allergic to Ginkgo biloba extract or one of the other components of this medicine,
  • during pregnancy.

dosage

• Always take this medicine exactly after consultation with your doctor or pharmacist. Ask your doctor or pharmacist if you are not sure.
• The recommended dose for adults and older patients is 1 and 1/2 film -coated tablet twice a day.
• The twice daily intake should take place in the morning and evening.
• Children and adolescents
  • There is no relevant indication for children and adolescents.
• Special patient groups
  • There is no data for dosage in the event of limited kidney or liver function.
• Duration of the application
  • The treatment should be at least 8 weeks.
  • If the symptoms have not improved after 3 months or the symptoms of the disease will increase, the doctor must check whether the continuation of the treatment is still justified.

 

• If you have taken a larger amount than you should
  • No cases of overdose are known. They could increasingly suffer symptoms as described in the "side effects" category.
  • If you have taken an overdose of Ginkgo, contact your doctor or seek medical advice because you may need medical treatment.

 

• If you have forgotten the intake
  • Do not take the double amount if you have forgotten the prior intake.

 

• If you have any further questions about taking this medicine, please contact your doctor or pharmacist.

Taking

• The film -coated tablets are taken orally. Do not take the tablets on the back. The tablets should be swallowed as a whole (not chewed) with liquid, preferably with a glass of drinking water. The intake can take place independently of the meals.

Patient information

• Warnings and Precautions
  • Please speak to your doctor or pharmacist before taking the medicine:
    • if you have a pathologically increased tendency to bleed (hemorrhagic diathesis) and at the same time treatment with blood -thinning medication,
    • if you are known to an antiquity (epilepsy),
    • if an operation is planned in the next 3 to 4 days,
    • when you take Efavirenz.
  • Talk to your doctor or pharmacist if the symptoms deteriorate during treatment.
  • Children and adolescents
    • There is no relevant indication for children and adolescents.

 

• Wateriness and ability to operate machines
  • Your doctor will tell you whether your illness is allowed to drive you and operate machines.
  • There were no sufficient studies on the effects on the traffic and operating machines.

Pregnancy

• If you are pregnant or breastfeed, or if you suspect that you are pregnant or intend to become pregnant, ask your doctor or pharmacist for advice before taking this drug.
• Pregnancy
  • Since there are individual indications that ginkgo-containing preparations could increase the willingness to bleed, this medicine must not be taken during pregnancy.
• Breastfeeding
  • This medicine should not be used during breastfeeding because there is no sufficient examinations. It is not known whether the ingredients of the extract change into breast milk.

Hints

Binko® Memo 80 mg film-coated tablets: active ingredient: Ginko-Biloba-Blätter-Dreocktextrakt. Area of application: to improve age -related cognitive impairment and quality of life in light dementia. Warnings: contains lactose, glucose and sodium. Status: 06/20-1. Read the package supplement and ask your doctor or pharmacist for risks and side effects. Klinge Pharma GmbH, 83607 Holzkirchen, Germany

Manufacturer:  Klinge Pharma GmbH, Bergfeldstraße 9, 83607 Holzkirchen